Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Zhihui Li, Xianxuan Wang, Keyan Yang, Lei Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 599.

https://doi.org/10.1182/blood-2024-200684

Published: 2024

Journal Articles

Chimeric Antigen Receptor T Cell Therapy Bridged to the Second Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Toxicity Conditioning for B-Cell Acute Lymphoblastic Leukemia Relapsed after the First Transplant

Yongqiang Zhao, Yanzhi Song, Zhihui Li, Feifei Li, Dongfang Yang, Rui Wang, Fang Fang, Huiyu Li, Tong Wu

Blood (2024) 144 (Supplement 1): 3544.

https://doi.org/10.1182/blood-2024-202852

Published: 2024

Journal Articles

Long-Term Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Resistant Ph+ Acute B Lymphoblastic Leukemia That Cannot Get MRD- Remission after Multi-Line Treatment

Yanzhi Song, Erhui Yuan, Qishu Qin, Qi Wang, Zhanxiang Liu, Kong Gao, Zhihui Li, Yongqiang Zhao, Tong Wu

Blood (2024) 144 (Supplement 1): 2164.

https://doi.org/10.1182/blood-2024-202388

Published: 2024

Journal Articles

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Keyan Yang, Lei Wang, Xianxuan Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 4922.

https://doi.org/10.1182/blood-2024-200716

Published: 2024

Journal Articles

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Zhihui Li, Qinlong Zheng, Keyan Yang, Teng Xu, Lei Wang, Xianxuan Wang, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2023) 142 (Supplement 1): 239.

https://doi.org/10.1182/blood-2023-180834

Published: 2023

Journal Articles

Rituximab and Bortezomib for Patients with Newly Diagnosed Acquired Haemophilia: Single Arm, Single Center, Prospective Phase 2 Study

Huacong Cai, Xinxin Cao, Shujie Wang, Yongqiang Zhao, Jian Li, Tie-nan Zhu

Blood (2022) 140 (Supplement 1): 2715–2716.

https://doi.org/10.1182/blood-2022-166513

Published: 2022

Journal Articles

Profiles of Germline Predisposition Gene Variants in Hematologic Disorders and Its Impact on Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation

Zhihui Li, Keyan Yang, Qinlong Zheng, Xianxuan Wang, Fan Wu, Jing Li, Xiaopei Wen, Caiyan Zhang, Jingjing Wang, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2022) 140 (Supplement 1): 7693–7694.

https://doi.org/10.1182/blood-2022-166695

Published: 2022

Journal Articles

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation after Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Zhihui Li, Qinlong Zheng, Fan Wu, Caiyan Zhang, Teng Xu, Yongqiang Zhao, Yanzhi Song, Tong Wu

Blood (2021) 138 (Supplement 1): 1820.

https://doi.org/10.1182/blood-2021-150192

Published: 2021

Journal Articles

Allogeneic-Hematopoietic Stem Cell Transplantation Is Effective and Safe for Relapsed/ Refractory B-ALL Patients Who Cannot Get Remission or MRD Negative after CART Treatment

Yanzhi Song, Zhihui Li, Yongqiang Zhao, Fan Yang, Erhui Yuan, Qi Wang, Tong Wu

Blood (2021) 138 (Supplement 1): 1843.

https://doi.org/10.1182/blood-2021-146357

Published: 2021

Journal Articles

Better Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning in Elderly Patients with Hematological Malignancies

Yongqiang Zhao, Yanzhi Song, Fan Yang, Feifei Li, Dongfang Yang, Tong Wu

Blood (2021) 138 (Supplement 1): 4864.

https://doi.org/10.1182/blood-2021-149871

Published: 2021

Journal Articles

Excellent Outcomes of the Second Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies with Reduced Toxicity Conditioning and Donor Change

Yongqiang Zhao, Yanzhi Song, Zhihui Li, Fan Yang, Feifei Li, Dongfang Yang, Tong Wu

Blood (2021) 138 (Supplement 1): 4891.

https://doi.org/10.1182/blood-2021-150087

Published: 2021

Journal Articles

Influence of Inherited and Acquired Hematological and Immunological Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Yongqiang Zhao, MD, Yanzhi Song, MD, Caiyan Zhang, PhD, Qinlong Zheng, PhD, Chunrong Tong, Tong Wu, MD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-139220

Published: 2020

Journal Articles

Interleukin-7 Receptor Gene Heterozygous Mutations in Recipients Significantly Increase Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Fan Yang, Yang LEI, MD, Qinlong Zheng, PhD, Caiyan Zhang, PhD, Yueqian Feng, MD, Changwei Dong, MD, Zhihui Li, Yongqiang Zhao, MD, Yanzhi Song, MD, Tong Wu, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-140164

Published: 2020

Journal Articles

Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia

Shuangyou Liu, Biping Deng, BS, MD, Jing PAN, Zhichao Yin, Yuehui Lin, Zhuojun Ling, Tong Wu, MD, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong

Blood (2019) 134 (Supplement_1): 228.

https://doi.org/10.1182/blood-2019-123051

Published: 2019

Journal Articles

Potential Influence of Hematological or Immunological Hereditary Predisposition Genes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Qinlong Zheng, Yongqiang Zhao, Yanzhi Song, Fan Yang, Min Jiang, Chunrong Tong, Tong Wu, MD

Blood (2019) 134 (Supplement_1): 2037.

https://doi.org/10.1182/blood-2019-126339

Published: 2019

Journal Articles

Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Shuangyou Liu, Biping Deng, Yuehui Lin, Zhichao Yin, Jing Pan, Tong Wu, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong

Blood (2018) 132 (Supplement 1): 2126.

https://doi.org/10.1182/blood-2018-99-111856

Published: 2018

Journal Articles

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

Renchi Yang, MD, Ming Hou, MD, Junmin Li, MD PhD, Jie Jin, MD, Meijuan Huang, MD, Ziqiang Yu, MD, Xiaojun Xu, Xiaohui Zhang, Xin Du, MD, Ting Niu, MD PhD, Xiaoyan Ke, MD PhD, Jianmin Wang, MD PhD, Jing Liu, MD, Jing Sun, MD, Yongqiang Zhao, MD& PhD, Hua Lu, MD, Haiyi Guo, MD, Belinda Hsu, Senior statistician

Blood (2014) 124 (21): 1464.

https://doi.org/10.1182/blood.V124.21.1464.1464

Published: 2014

Journal Articles

The Interaction Between Stromal Cell-Derived Factor 1 Alpha (SDF-1α) and Dickkopf-1 (DKK-1) Mediates Myeloma Bone Disease

Junling Zhuang, MD, PhD, Yi Da, MD, Xuan Wang, Tianjiao Li, BS, Shujie Wang, MD, PhD, Yongji Wu, MD, Daobin Zhou, MD, Yongqiang Zhao, MD & PhD

Blood (2012) 120 (21): 1824.

https://doi.org/10.1182/blood.V120.21.1824.1824

Published: 2012

Journal Articles

Telomerase Gene Screening and Telomere Overhang Detection in Chinese Patients with Acute Myeloid Leukemia

Siyi Yan, MD, Bing Han, MD, PhD, Yongji Wu, MD, Daobin Zhou, MD, Yongqiang Zhao

Blood (2011) 118 (21): 1467.

https://doi.org/10.1182/blood.V118.21.1467.1467

Published: 2011

Journal Articles

Telomerase Gene Mutation Screening and Telomere Length Detection in Chinese Patients with Bone Marrow Failure Syndrome.

Bing Han, MD, PhD, Bo Liu, MD, PhD, Yongqiang Zhao, MD, PhD

Blood (2008) 112 (11): 1047.

https://doi.org/10.1182/blood.V112.11.1047.1047

Published: 2008

NARROW

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Chimeric Antigen Receptor T Cell Therapy Bridged to the Second Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Toxicity Conditioning for B-Cell Acute Lymphoblastic Leukemia Relapsed after the First Transplant

Long-Term Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Resistant Ph+ Acute B Lymphoblastic Leukemia That Cannot Get MRD- Remission after Multi-Line Treatment

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Rituximab and Bortezomib for Patients with Newly Diagnosed Acquired Haemophilia: Single Arm, Single Center, Prospective Phase 2 Study

Profiles of Germline Predisposition Gene Variants in Hematologic Disorders and Its Impact on Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation after Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Allogeneic-Hematopoietic Stem Cell Transplantation Is Effective and Safe for Relapsed/ Refractory B-ALL Patients Who Cannot Get Remission or MRD Negative after CART Treatment

Better Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning in Elderly Patients with Hematological Malignancies

Excellent Outcomes of the Second Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies with Reduced Toxicity Conditioning and Donor Change

Influence of Inherited and Acquired Hematological and Immunological Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Interleukin-7 Receptor Gene Heterozygous Mutations in Recipients Significantly Increase Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia

Potential Influence of Hematological or Immunological Hereditary Predisposition Genes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

The Interaction Between Stromal Cell-Derived Factor 1 Alpha (SDF-1α) and Dickkopf-1 (DKK-1) Mediates Myeloma Bone Disease

Telomerase Gene Screening and Telomere Overhang Detection in Chinese Patients with Acute Myeloid Leukemia

Telomerase Gene Mutation Screening and Telomere Length Detection in Chinese Patients with Bone Marrow Failure Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only